Newsletter 4-2022

Our final Newsletter of 2022 highlights research articles published in 2022 using QconCATs by PolyQuant


Year End Special Offer

Save up to -50% on Cov-MS Peptide Reference Standards and on QCAL and RePLiCal Calibration Standards until Dec. 31, 2022


Proteina22 Conference in Magdeburg

PolyQuant visited the Proteina22 conference in Magdeburg from 3rd-4th November 2022. We were happy to use this opportunity for networking between research and industry.


7th Halle Conference on Recombinant Proteins

PolyQuant visited the 7th Halle Conference on Recombinant Proteins from October 13th-14th, an international forum for presenting and discussing current developments in recombinant protein production. Our poster: “Comprehensive analysis of protein quality using quantitative LC-MS/MS technology“ Short version


Newsletter 3-2022

Special feature: Quality control of recombinant proteins and medical products using LC-MS/MS; Special feature technology: DosCAT; YPIC Challenge: The winners are…More….


Newsletter 2-2022

Special featured product: RePLiCal; Summer Special Offer: Save 15% on QconCATs and up to 50% on Calibration Standards; Research Highlights; YPIC Challenge #3; QconCAT Kit – Cardiovascular Diseases. More….


QconCAT Kit – Cardiovascular Diseases

Now available: QconCAT Kit for detection and absolute quantification of plasma proteins linked to cardiovascular diseases. More….


Newsletter 1-2022

Celebrating 15 years of QconCATs by PolyQuant and highlighting past projects and current challenges in proteomics. More….

More newsletters can be found in our archive.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

PolyQuant will save the submitted personal information to be able to  process your request. We will not transfer your data to third parties. You can withdraw the permission to save your personal information at any  time. For more information, please read our privacy policy

Powered by Sendinblue. By completing and submitting this form you consent to the transfer of the submitted data to Sendinblue and the processing of the data according to their terms of use.

Kommentare sind geschlossen.